Sontag Advisory »

Perspective Therapeutics shares owned by Sontag Advisory

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Sontag Advisory from 13F filings

Historical chart of Sontag Advisory investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Sontag Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Sontag Advisory

Quarter filed Position value Share count Share price at filing
2025-09-30 $138 40 3.45

More positions owned by Sontag Advisory

iShares Core S&P 500 ETF Etf (IVV)
Vanguard MSCI EAFE ETF Etf (VEA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
iShares Core S&P Mid-Cap ETF Etf (IJH)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab International Equity ETF Etf (SCHF)
Vanguard FTSE Emerging Markets ETF Etf (VWO)
Vanguard Index Fds Growth Etf (VUG)
iShares Core S&P Small-Cap ETF Etf (IJR)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Extended Market ETF Etf (VXF)
Vanguard Index Fds Large Cap Etf (VV)

View all positions for Sontag Advisory

Top funds holding Perspective Therapeutics

FMR
BlackRock
Vanguard Group
Avidity Partners Management
Millennium Management
Morgan Stanley
Nicholson Wealth Management Group
Geode Capital Management
Nuveen
State Street Corporation
Hills Bank And Trust Company
UBS Group
Walleye Trading Advisors
Charles Schwab Investment Management
Two Sigma Investments

View all funds holding Perspective Therapeutics